Prospective of low dose naltrexone use in treatment of autoimmune pathology and endometriosis
There are still many complex issues in the management of autoimmune pathologies in gynecology and reproductology, endometriosis in particular. Naltrexone, a competitive antagonist of opiate receptors in the central and peripheral nervous systems, reveals new qualities such as effects on autoimmune p...
Saved in:
Main Authors: | O. V. Golianovskyi (Author), O. O. Andrienko (Author), O. V. Furman (Author), Phil Boyle (Author) |
---|---|
Format: | Book |
Published: |
Publishing House TRILIST,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Low Dose Naltrexone - Efficacy and safety of off-label use therapy.
by: Andrzej Stańczak
Published: (2020) -
Low-dose naltrexone as treatment for epidermolysis bullosa pruriginosa-associated refractory pruritus
by: Lauren C. LaMonica, MPH, et al.
Published: (2023) -
Ultra-low dose naltrexone attenuates chronic morphine-induced gliosis in rats
by: Milne Brian, et al.
Published: (2010) -
Intranasal Low-Dose Naltrexone Against Opioid Side Effects: A Preclinical Study
by: Laura Micheli, et al.
Published: (2020) -
Naltrexone Implant for Opioid Use Disorder
by: Amber N. Edinoff, et al.
Published: (2021)